Allitinib
WebAllitinib metabolite M3 C17H13ClN4O3 - PubChem Apologies, we are having some trouble retrieving data from our servers... PUGVIEW FETCH ERROR: 403 Forbidden National Center for Biotechnology Information 8600 Rockville Pike, Bethesda, MD, 20894 USA Contact Policies FOIA HHS Vulnerability Disclosure National Library of Medicine WebAllitinib (AST1306, 35) is selective irreversible dual EGFR and HER2 inhibitor. AST1306 was found to inhibit, through covalent bond interaction with Cys797 and Cys805 in the catalytic domain of EGFR and HER2 respectively. Silva-Olieira et al. [ 71] reported the cytotoxicity of allitinib in large panel of 76 different human cancer cell lines.
Allitinib
Did you know?
WebDec 1, 2013 · Allitinib (AST1306, N-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)-quinazolin-6-yl) acrylamide, Fig. 1), an analog of lapatinib, is a novel irreversible inhibitor of EGFR and ErbB2.Allitinib is currently in clinical trials in China for the treatment of solid tumors. Pilot studies in our laboratory demonstrated that allitinib was absorbed quickly, …
WebAllitinib (AST1306, 35) is selective irreversible dual EGFR and HER2 inhibitor. AST1306 was found to inhibit, through covalent bond interaction with Cys797 and Cys805 in the … WebAllitinib (AST-1306) Allitinib (AST-1306, AST-6) is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R, more potent to ErbB2-overexpressing cells, 3000-fold selective for ErbB family than other kinases. Pan: ErbB4, IC50: 0.8 nM: S1011: Afatinib (BIBW2992)
WebDec 17, 2024 · Anlotinib Hydrochloride Capsule: Oral on an empty stomach, once a day, 1 capsule each time, orally for 2 consecutive weeks, stop for 1 week Allitinib Tablets：The … WebAllitinib (AST1306, 35) is selective irreversible dual EGFR and HER2 inhibitor. AST1306 was found to inhibit, through covalent bond interaction with Cys797 and Cys805 in the …
WebNCT04671303: Phase 2 Interventional Not yet recruiting Lung Cancer (2024)
http://www.fluoroprobe.com/archives/tag/%e6%8a%bd%e6%bb%a4%e5%ba%a7 proton symbol chargeWebAST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively. All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use. Allitinib tosylate, CAS 1050500-29-2 Please contact us for prices and availability for the specification of product you are interested at. proton technologies file on pcWebConsidering the active intermediates, the crown ether ring of icotinib is oxidated to open to form an aldehyde; the indolylidene ring of famitinib is oxidated followed by rearrangement to form a quinone- imine; the α, β-unsaturated carbonyl group of allitinib is oxidated to form an epoxide, these intermediates are capable of covalently ... proton teamWebAllitinib related products. MedChemExpress provides thousands of inhibitors, modulators and agonists with high purity and quality, excellent customer reviews, precise and professional product citations, tech support and prompt delivery. proton tabletsWebAllitinib C24H18ClFN4O2 CID 24739943 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more. proton symport icm rhodobacterWebMar 15, 2016 · Allist Pharmaceuticals, a drug development company in China, was developing allitinib, an irreversible selective EGFR and ErbB2 inhibitor, for the treatment … resort pass daytona beachWebAllitinib is a novel anilino-quinazoline compound that inhibits ErbB tyrosine kinases: epidermal growth factor receptor (EGFR) and ErbB2. It inhibits EGFR and ErbB2 with … proton tech support